Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use disorder, a new study suggests.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder. How the meds work in the brain.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink

A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol and cocaine.

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new study confirms there's likely something to the anecdotes, with a staggering 30 percent reduction in alcohol consumption per drinking day for those given the medication,